There’s an essential replace on the James Gunn period of DC Studios movies, with a brand new title moving into the ring to script Warner Bros.’ Supergirl: Lady of Tomorrow.
Ana Nogueira has been employed to pen the Supergirl movie for the upcoming re-imagining of the DC heroine. The Hollywood Reporter broke the information and likewise revealed that Nogueira had been employed onto the Sasha Calle-led function that was within the works earlier than The Flash got here and went. Calle was that movie’s standout and we hope that they will return to play this model of Kara, which is impressed by the Tom King run of comics that Nogueira is about to adapt. Finest recognized for the CW’s The Vampire Diaries, Nogueira can also be a playwright and actress whose work on the final Supergirl script earned her an total writing take care of DC Studios.
DC head Gunn spoke to the hope that this tackle Kara Zor-El would stand other than his upcoming Superman: Legacy movie. “Superman is a man despatched to Earth and raised by loving mother and father, the place Supergirl on this story, she is a personality raised on a piece of Krypton,” THR quotes Gunn as saying in a video revealed to what was then often called Twitter. “She watched all people round her perish in some horrible approach, so she’s a way more jaded character.” Extra lately, he welcomed Nogueira to the mission on Instagram, which you’ll be able to see under: “A hearty public welcome to Ana Nogueira to the DC Studios household. Ana is a tremendous author whose screenplay adaptation of Lady of Tomorrow is above and past something I hoped it could be. We’re excited to be transferring ahead on this distinctive tackle Supergirl on this lovely, star-spanning story.”
Control io9 for any updates concerning Supergirl: Lady of Tomorrow and extra DC Studios information.
Need extra io9 information? Take a look at when to count on the newest Marvel, Star Wars, and Star Trek releases, what’s subsequent for the DC Universe on movie and TV, and every thing you have to find out about the way forward for Physician Who.
